Store launching soon — browse the catalog and join the waitlist to be notified at launch.
✦USPS Priority Mail1–3 day delivery across the U.S.Free on orders over $200
Store launching soon — browse the catalog and join the waitlist to be notified at launch.
Your cart is empty
Peptide Bioregulator
Also known as Lys-Glu-Asp-Ala (KEDA)
Livagen is the tetrapeptide Lys-Glu-Asp-Ala, studied in research on hepatic tissue models and on chromatin activation in lymphocytes.
🚀 Launching soon — join the waitlist to be notified when this product is available.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Livagen is the tetrapeptide Lys-Glu-Asp-Ala, studied in research on hepatic tissue models and on chromatin activation in lymphocytes.
Experimental work examines tissue-specific short-peptide activity in cultures from animals and donors of different ages.
Third-party tested for purity, ID, quantity.
Livagen is among the better-documented short peptide bioregulators. Published studies have examined chromatin decondensation in lymphocytes from older donors, protein-synthesis rhythms in hepatocyte cultures, and digestive-enzyme activity in rodent models.
That work sits within a broader research model in which short peptides are proposed to act on heterochromatin and gene expression rather than through classical receptor pharmacology.
Livagen was characterized as one of a series of tissue-directed tetrapeptides in the Russian peptide-bioregulator programme, with an emphasis on hepatic tissue.
Subsequent research extended into lymphocyte chromatin studies, which became some of the most cited work in this compound class.
Research into Livagen focuses on chromatin activation in ageing lymphocytes and on tissue-specific effects in hepatic culture models. Frameworks evaluate heterochromatin decondensation, protein-synthesis rhythms, and enzyme activity under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of Livagen. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Effects of Livagen peptide on chromatin activation in lymphocytes from old people
PubMedEffects of short peptides on lymphocyte chromatin in senile subjects
PubMedRhythm of protein synthesis in cultures of hepatocytes from rats of different ages. Norm and effect of the peptide livagen
PubMedEffect of peptide Livagen on activity of digestive enzymes in gastrointestinal tract and non-digestive organs in rats of different ages
PubMedRelated
Pentadecapeptide studied for angiogenesis signaling, tissue repair pathways, and cellular regeneration research
From$50.00
$60.00
Small molecule studied for metabolic regulation, NAD pathways, and cellular energy signaling
From$40.00
Dual peptide complex studied for actin signaling, tissue regeneration pathways, and recovery system research
From$0.00
Oral peptide format studied for systemic repair signaling and gastrointestinal pathway research
$140.00
